$ Value
$0
Shares
45,000
Price
$0
Filed
Jun 12
Insider
Name
Dreyfus Andrew
Title
—
CIK
0001670893
Roles
Transaction Details
Transaction Date
2025-06-10
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
228,313
Footnotes
The restricted stock, granted pursuant to the Second Amended and Restated Non-employee Director Compensation Policy, effective January 1, 2024, vests in full on the date immediately preceding the date of the annual meeting of stockholders for the next calendar year. | Since the date of the reporting person's last ownership report, the individual transferred 4,917 shares of Class A common stock to the individual's ex-spouse pursuant to a domestic relations order. The reporting person no longer reports as beneficially owned any securities owned by the individual's ex-spouse.
Filing Info
Other Insiders at IRWD (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| DENNER ALEXANDER J | — | $20.5M | 2026-03-17 |
|
MCCOURT Thomas A
Chief Executive Officer
|
— | $740K | 2026-03-10 |
|
Shetzline Michael
SVP, CMO, Head-Res&Drug
|
— | $122K | 2026-03-10 |
|
Silver Ronald
Principal Accounting Officer
|
— | $90K | 2026-03-10 |
|
John Minardo
Chief Legal Officer
|
— | $136K | 2026-03-10 |
|
Martini Gregory S.
Chief Financial Officer
|
— | $82K | 2026-03-10 |
|
Gaskins Tammi L
Chief Commercial Officer
|
— | $80K | 2026-03-10 |